These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14626202)

  • 1. [Cytokines as tumor markers in breast cancer].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2003; 57(4):455-63. PubMed ID: 14626202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor markers useful for diagnosis and monitoring of lung neoplasm].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(1):93-118. PubMed ID: 11993454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hematopoietic cytokines as tumor markers].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2001; 55(3):449-65. PubMed ID: 11505643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New tumour markers useful in diagnostics and monitoring of cervical cancer].
    Bedkowska GE; Lawicki S; Szmitkowski M
    Przegl Lek; 2007; 64(12):1022-7. PubMed ID: 18595508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor markers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor markers in gynecological and breast cancer].
    Jobo T; Sato R; Kuramoto H
    Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour markers in breast cancer--EGTM recommendations. European Group on Tumor Markers.
    Anticancer Res; 1999; 19(4A):2803-5. PubMed ID: 10470245
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer screening and biomarkers.
    Brooks M
    Methods Mol Biol; 2009; 472():307-21. PubMed ID: 19107439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biomarkers in breast cancer].
    Kurebayashi J
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1021-6. PubMed ID: 15272579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
    Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
    Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
    Zheng H; Luo RC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results.
    Zervoudis S; Peitsidis P; Iatrakis G; Panourgias E; Koureas A; Navrozoglou I; Dubois JB
    J BUON; 2007; 12(4):487-92. PubMed ID: 18067207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients.
    Kozłowski L; Zakrzewska I; Tokajuk P; Wojtukiewicz MZ
    Rocz Akad Med Bialymst; 2003; 48():82-4. PubMed ID: 14737948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of breast cancer and lymph node metastatic status with tumour markers using logistic regression models.
    Hwa HL; Kuo WH; Chang LY; Wang MY; Tung TH; Chang KJ; Hsieh FJ
    J Eval Clin Pract; 2008 Apr; 14(2):275-80. PubMed ID: 18284517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of systemic chemotherapy on clinical status and biological and immunologic markers in patients with breast cancer].
    Orlova RV; Chernetsova LF; Matveeva ON
    Vopr Onkol; 2007; 53(4):414-8. PubMed ID: 17969403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum tumor markers in patients with breast cancer.
    Lumachi F; Basso SM
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):921-31. PubMed ID: 15485325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
    Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
    Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
    Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells in breast cancer.
    Ignatiadis M; Georgoulias V; Mavroudis D
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.